Core Insights - The company has a planned production capacity of 20,000 tons/year for lithium hexafluorophosphate and 10,000 tons/year for lithium bis(fluorosulfonyl)imide, but production is limited due to market conditions [2] - The company does not produce PVDF-HFP water-based adhesives or sulfide electrolyte materials [2] - The company has formed strategic partnerships with leading domestic and international manufacturers to provide differentiated and customized product services, leveraging its technical expertise and production resources [2]

Group 1 - The company, Linghua Technology (002250.SZ), confirmed on September 22 that it does not have any business related to photoresist [1]

Group 1 - The company has planned an annual production capacity of 20,000 tons for lithium hexafluorophosphate (LiPF₆) and 10,000 tons for lithium bis(fluorosulfonyl)imide (LiFSI) [1] - Due to market conditions, the actual output of these products is limited [1] - The company does not currently produce PVDF-HFP water-based adhesives or sulfide electrolyte materials [1] Group 2 - The company has formed strategic partnerships with leading domestic and international manufacturers [1] - It leverages its technical expertise and production resources to provide differentiated and customized product services [1] - The company aims to develop and offer various competitive key chemicals in collaboration with its customers [1]

Core Insights - The chemical industry in China is experiencing mixed performance, with overall revenue and net profit growth of 2.35% and 3.92% respectively in the first half of 2025 compared to the previous year [1] - A total of 237 out of 436 listed chemical companies reported year-on-year net profit growth, with 124 companies exceeding 30% growth [4] Industry Performance - Non-metal materials, plastics, agricultural chemicals, and chemical products showed significant net profit growth, with increases of 21.1%, 19.77%, 14.66%, and 3.08% respectively [1] - Conversely, chemical fibers, rubber, and chemical raw materials faced declines in net profit, with decreases of -18.5%, -15.59%, and -2.73% respectively [1] - In the plastics sector, synthetic resins and modified plastics had notable net profit increases of 34.17% and 23.08% [2] - The agricultural chemicals sector saw exceptional growth in pesticides, potassium fertilizers, and compound fertilizers, with net profit increases of 120.54%, 40.1%, and 13.25% respectively [2] - The chemical products sector also performed well, particularly in fluorine chemicals and food additives, with net profit growth of 89.53% and 37.98% [2] - The chemical raw materials sector had strong performers like other chemical raw materials and chlor-alkali, with net profit increases of 36.18% and 26.75% [3] Company Highlights - Notable companies such as Xinda Co., Su Li Co., and Lianhua Technology reported net profit growth exceeding 1000% in the first half of 2025 [4] - New and Cheng achieved a revenue of 11.1 billion yuan, a 12.76% increase, and a net profit of 3.6 billion yuan, a 63.46% increase [5] - Juhua Co. reported total revenue of 13.33 billion yuan, a 10.36% increase, and a net profit of 2.05 billion yuan, a 146.97% increase [5] Institutional Research Focus - Institutional research is concentrated on identifying growth drivers for the second half of the year, R&D investment directions, sources of performance growth, overseas business development, and market value management [6][7] - Companies like New and Cheng are focusing on nutrition, flavoring, and new materials to enhance revenue [7] - Huami New Materials reported a 16.20% increase in R&D investment, focusing on automotive and aerospace sectors [7] - Companies are actively expanding overseas markets, with efforts in rail transit and rubber tape projects in Europe [8]

Core Points - On September 16, 2025, the company will hold a staff representative meeting in its conference room [2] - The staff representatives unanimously agreed to elect Mr. Fan Xiaobin as the employee representative director of the company's ninth board of directors [2]

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected stock price increase of over 15% relative to the industry index in the next six months [4]. Core Viewpoints - The company's performance in the first half of 2025 exceeded market expectations, showing signs of recovery with a revenue increase of 5.76% year-on-year and a significant net profit growth of 1481.94% [1][2]. - The recovery in profitability from the agricultural protection business and significant growth in the pharmaceutical sector are key drivers of the company's improving performance [2][8]. - The company is focusing on expanding its overseas operations and enhancing its product offerings in the agricultural protection and pharmaceutical sectors, which are expected to contribute to long-term growth [8][9]. Financial Summary - **Revenue Forecast**: The company is projected to achieve revenues of 68.82 billion, 79.49 billion, and 90.29 billion yuan for 2025, 2026, and 2027, respectively, with year-on-year growth rates of 21.2%, 15.5%, and 13.6% [9]. - **Net Profit Forecast**: Expected net profits are 4.09 billion, 5.81 billion, and 7.28 billion yuan for the same years, with growth rates of 297.0%, 42.0%, and 25.2% [9]. - **Earnings Per Share (EPS)**: The projected EPS for 2025, 2026, and 2027 are 0.44, 0.63, and 0.79 yuan, respectively [9]. - **Valuation Ratios**: The price-to-earnings (P/E) ratios are expected to be 25.6, 18.0, and 14.4 for the years 2025, 2026, and 2027 [9]. Business Segment Performance - **Agricultural Protection**: Revenue from agricultural intermediates was 17.02 billion yuan, with a year-on-year decline of 9.13%. However, the gross margin improved to 24.99%, up 9.48 percentage points year-on-year [2]. - **Pharmaceuticals**: The pharmaceutical segment saw revenue of 10.18 billion yuan, a year-on-year increase of 42.80%, with a stable gross margin [8]. - **New Energy**: The company has commercialized four new energy products and is advancing several others through various stages of development, indicating potential for a second growth curve [9].

Group 1 - The company, Lianhua Technology, announced the convening of its 9th First Board Meeting on September 16, 2025, to discuss the election of a director for company affairs [1] - For the first half of 2025, Lianhua Technology's revenue composition was 99.64% from industrial operations and 0.36% from other businesses [1] - As of the report date, Lianhua Technology's market capitalization was 10.2 billion yuan [1]

特此公告。 联化科技股份有限公司董事会 二〇二五年九月十七日 证券代码：002250 证券简称：联化科技 公告编号：2025-041 联化科技股份有限公司 关于选举第九届董事会职工代表董事的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 联化科技股份有限公司（以下简称"公司"）根据《中华人民共和国公司法》 （以下简称"《公司法》"）、《联化科技股份有限公司章程》（以下简称"《公司章 程》"）等有关规定，公司于2025年9月16日在公司会议室召开职工代表大会。经 与会职工代表认真审议，一致同意选举樊小彬先生为公司第九届董事会职工代表 董事，任期自本次职工代表大会选举通过之日起至公司第九届董事会届满之日止。 樊小彬先生简历附后。 樊小彬先生符合《公司法》《公司章程》等法律法规和制度规定的董事任职 资格及条件。公司第九届董事会中兼任公司高级管理人员以及由职工代表担任的 董事人数总计不超过公司董事总数的二分之一。 附件： 樊小彬简历 樊小彬先生，中国国籍，1976年3月出生，硕士。历任联化科技监事、研发 中心副主任、农药与精细化学品研发部主任、总裁助理。兼任江苏 ...

证券代码：002250 证券简称：联化科技 公告编号：2025-040 联化科技股份有限公司 2025 年第一次临时股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会无否决议案的情形。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1、会议时间：2025年9月16日（星期二）15时00分 2、会议地点：浙江省台州市黄岩区江口经济开发区永椒路8号会议室 3、会议召集人：联化科技股份有限公司董事会 公司董事、监事、高级管理人员和见证律师出席或列席了会议，符合《公司法》 和《公司章程》的有关规定。 二、议案审议表决情况 本次股东大会按照会议议程，以现场记名投票与网络投票表决方式审议通过了 如下决议： 1、审议通过《关于修订<公司章程>及相关议事规则的议案》，该项议案获得出 席本次股东大会有效表决权股份总数的 2/3 以上通过。 表决结果： 4、会议方式：现场投票与网络投票相结合的方式 5、现场会议主持人：董事长王萍女士 6、会议的召集、召开与表决程序符合《公司法》《上市公 ...

北京市嘉源律师事务所 关于联化科技股份有限公司 2025年第一次临时股东大会的 法律意见书 西城区复兴门内大街 158 号远洋大厦 4 楼 中国·北京 北京市嘉源律师事务所 北京BEIJING·上海SHANGHAI·深圳SHENZHEN·香港HONG KONG·广州GUANGZHOU·西安XI'AN 致：联化科技股份有限公司 关于联化科技股份有限公司 2025年第一次临时股东大会的 法律意见书 嘉源(2025)-04-683 北京市嘉源律师事务所（以下简称"本所"）接受联化科技股份有限公司（以 下简称"公司"）的委托，根据《中华人民共和国公司法》（以下简称"《公司 法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公 司股东会规则》（以下简称"《股东会规则》"）等现行有效的法律、行政法规、 部门规章、规范性文件（以下简称"法律法规"）以及《联化科技股份有限公司 章程》（以下简称"《公司章程》"）的有关规定，指派本所律师对公司2025 年第一次临时股东大会（以下简称"本次股东大会"）进行见证，并依法出具本 法律意见书。 为出具本法律意见书，本所指派律师现场见证了本次股东大会，查阅了公司 提供的 ...